Healthcare >> Analyst Interviews >> November 24, 2003

In-vitro Diagnostics: Steven Hamill – U.s. Bancorp Piper Jaffray Inc

STEVEN M. HAMILL is a Vice President and Senior Research Analyst at U.S. Bancorp Piper Jaffray, covering diagnostics and blood management and safety. Before joining U.S. Bancorp Piper Jaffray in July 2003, he was a Senior Research Analyst at RBC Capital Markets in Minneapolis, where he also covered medical device companies. Prior to working on Wall Street, he was a manager in the Business Valuation Practice for Arthur Andersen LLP in Minneapolis and Milwaukee, for more than seven years. He graduated from Marquette University in Milwaukee, magna cum laude, with Bachelor of Science degrees in Economics and Finance. He holds the Chartered Financial Analyst designation and is a member of the Association for Investment Management and Research. Profile
TWST: What is your coverage area and how does it fit into the overall

game plan at U.S. Bancorp Piper Jaffray?

Mr. Hamill: Piper Jaffray has one of the deepest healthcare research

teams in